Dyadic CEO Mark Emalfarb Interview with Yahoo finance

(7:10)

Dyadic CEO Mark Emalfarb Presents at AVMI

(53:45)

Dyadic International, Inc. (NASDAQ: DYAI) | CEO Mark Emalfarb | Innovators with Jane King

(8:32)

SCN's Wendy Gillette Interviews CEO Mark Emalfarb of Dyadic International, Inc. (DYAI)

(7:10)

Sequire Spotlight Presents: Dyadic International (DYAI) - Next Generation Proteins for World Health

(12:6)

Dyadic CEO remarks on steps the federal gov't can take to speed along drug manufacturing

(5:58)

Dyadic CEO Mark Emalfarb presents at H.C. Wainwright Global Life Sciences Conference

(32:50)

Dyadic CEO Mark Emalfarb presents at 33rd Annual Roth Conference

(32:46)

Congresswoman Katie Porter grills billionaire CEO over pay disparity at JP Morgan

(2:36)

Interviewing the CEO of Y Combinator

(22:39)

Jensen Huang - CEO of NVIDIA | Podcast | In Good Company | Norges Bank Investment Management

(54:44)

Nanoco Group – executive interview (4 December 2024)

(11:21)

CEO need to be replaced if you don't find this 5 Quality, 5 Quality of great CEO, leadership funnel

(5:55)

The Dyad Process - What is a Dyad?

(8:29)

GoDaddy's CEO On The Company's Small Business Ecosystem And Finding Career Success | Forbes

(9:48)

26-Year-Old Self-Made Millionaire: Don't Waste Time On Self-Improvement | CNBC Make It.

(1:7)

A Conversation with Intel CEO: First 100 Days

(22:9)

Nvidia CEO Jensen Huang delivers keynote at CES [FULL KEYNOTE]

(1:57:41)

Only 1.7% of CEOs feel prepared for AI integration, says Cisco's Jeetu Patel

(4:6)

Dyadic International CEO reflects on 2018 accomplishments and reveals year end earnings

(7:38)

Jan 2021 Dyadic Investor Presentation

(22:3)

BIO CEO Investor Presentation February 2021

(24:53)

SCN's Wendy Gillette Interviews CEO Mark Emalfarb of Dyadic International, Inc DYAI

(7:10)

DYADIC's DYAI CEO, Mark Emalfarb, Details Company's Recent Inflection Point

(2:32)

A brief look into Dyadic's past and what the future may bring

(3:16)

Corona Virus

(5:19)

Dyadic Nasdaq Closing Bell Speech / Mark Emalfarb $DYAI

(6:53)

Mark Emalfarb of Dyadic at World Congress 2010

(5:12)

Dyadic International, Inc. (OTCQX: DYAI)

(4:6)

Dyadic International starts dosing in Phase 1 clinical trial DYAI-100 booster vaccine candidate

(6:32)